Poster De Conférence Année : 2018

Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis

Dates et versions

hal-01935071 , version 1 (26-11-2018)

Identifiants

Citer

F. Rollot, Romain Casey, Marc Debouverie, Gilles Edan, S. Wiertlewski, et al.. Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis. ECTRIMS 2018, Oct 2018, Berlin, Germany. Sage Journals, Multiple Sclerosis Journal, 24 (Issue 2), pp.344-345 / P677, 2018, ⟨10.1177/1352458518798590⟩. ⟨hal-01935071⟩
230 Consultations
0 Téléchargements

Altmetric

Partager

  • More